Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK

BMJ Open

Volumn 6, Issue 11, 2016, Pages

  Gharbi, Myriam ^a   Doerholt, Katja ^b   Vergnano, Stefania ^c   Bielicki, Julia Anna ^c   Paulus, Stéphane ^d   Menson, Esse ^e   Riordan, Andrew ^d   Lyall, Hermione ^f   Patel, Sanjay Valabh ^g   Bernatoniene, Jolanta ^h   Versporten, Ann ⁱ   Heginbothom, Maggie ^j   Goossens, Herman ⁱ   Sharland, Mike ^b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^e EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^f IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^g SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^h BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

ⁱ UNIVERSITY OF ANTWERP   (Belgium)

^j PUBLIC HEALTH WALES   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; PENICILLANIC ACID; PIPERACILLIN; PIPERACILLIN, TAZOBACTAM DRUG COMBINATION;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HOSPITALIZED CHILD; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PEDIATRIC WARD; POINT PREVALENCE SURVEY; PRESCRIPTION; QUESTIONNAIRE; TERTIARY CARE CENTER; TOTAL QUALITY MANAGEMENT; UNITED KINGDOM; ANALOGS AND DERIVATIVES; CLINICAL PRACTICE; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEY; HOSPITAL; HOSPITALIZATION; INAPPROPRIATE PRESCRIBING; INFANT; MALE; NATIONAL HEALTH SERVICE; PEDIATRICS; PRESCHOOL CHILD; PREVENTION AND CONTROL;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HOSPITALIZATION; HOSPITALS; HUMANS; INAPPROPRIATE PRESCRIBING; INFANT; MALE; PEDIATRICS; PENICILLANIC ACID; PIPERACILLIN; PRACTICE PATTERNS, PHYSICIANS'; STATE MEDICINE; SURVEYS AND QUESTIONNAIRES; UNITED KINGDOM;

EID: 84994709902     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-012675     Document Type: Article

References (34)

1. Baquero F, Negri MC, Morosini MI, et al. Antibiotic-selective environments. Clin Infect Dis 1998;27(Suppl 1):S5-11.
2. Jacobson KL, Cohen SH, Inciardi JF, et al. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms. Clin Infect Dis 1995;21:1107-13.
3. Davies SC, Gibbens N. UK five year antimicrobial resistance strategy 2013 to 2018. London: Department of Health, 2013.
4. WHO. The evolving threat of antimicrobial resistance: options for action. Geneva: World Health Organisation, 2012.
5. CDC. Antibiotic resistance threats in the United States. Atlanta: Centres for Disease Control and Prevention, 2013.
6. Charani E, Holmes AH. Antimicrobial stewardship programmes: the need for wider engagement. BMJ Qual Saf 2013;22:885-7.
7. Ashiru-Oredope D, Sharland M, Charani E, et al. Improving the quality of antibiotic prescribing in the NHS by developing a new antimicrobial stewardship programme: start smart-Then focus. J Antimicrob Chemother 2012;67(Suppl 1):i51-63.
8. Hersh AL, Beekmann SE, Polgreen PM, et al. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol 2009;30:1211-17.
9. Di Pentima MC, Chan S, Hossain J. Benefits of a pediatric antimicrobial stewardship program at a children's hospital. Pediatrics 2011;128:1062-70.
10. Gerber JS, Newland JG, Coffin SE, et al. Variability in antibiotic use at children's hospitals. Pediatrics 2010;126:1067-73.
11. Fridkin SK, Srinivasan A. Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States. Clin Infect Dis 2014;58:401-6.
12. Fortin E, Fontela PS, Manges AR, et al. Measuring antimicrobial use in hospitalized patients: a systematic review of available measures applicable to paediatrics. J Antimicrob Chemother 2014;69:1447-56.
13. Ibrahim OM, Polk RE. Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti Infect Ther 2012;10:445-57.
14. Polk RE, Fox C, Mahoney A, et al. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44:664-70.
15. ARHAI. Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) 4th Annual Report, February 2012-March 2013. Departement of Health, 2013:25.
16. ARHAI. Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection-Antimicrobial stewardship: "START SMART-THEN FOCUS" Guidance. London, UK: Department of Health, 2011:27.
17. NHS. Commissioning for Quality and Innovation (CQUIN)-Guidance for 2016/17. 2016. Available from https://www.england. nhs.uk/wp-content/uploads/2016/03/cquin-guidance-16-17-v3.pdf.
18. Amadeo B, Zarb P, Muller A, et al. European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother 2010;65:2247-52.
19. Versporten A, Bielicki J, Drapier N, et al. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother 2016;71:1106-17.
20. Henderson KL, Muller-Pebody B, Johnson AP, et al. First set-up meeting for Antibiotic Resistance and Prescribing in European Children (ARPEC). Euro Surveill 2009;14:pii: 19404 .
21. Versporten A, Sharland M, Bielicki J, et al. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J 2013;32:e242-53.
22. WHO. Guidelines for ATC classification and DDD assignment 2013. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2012.
23. Porta A, Esposito S, Menson E, et al. Off-label antibiotic use in children in three European countries. Eur J Clin Pharmacol 2010;66:919-27.
24. Porta A, Hsia Y, Doerholt K, et al. Comparing neonatal and paediatric antibiotic prescribing between hospitals: a new algorithm to help international benchmarking. J Antimicrob Chemother 2012;67:1278-86.
25. Spiegelhalter DJ. Funnel plots for comparing institutional performance. Stat Med 2005;24:1185-202.
26. De Luca M, Dona D, Montagnani C, et al. Antibiotic prescriptions and prophylaxis in Italian children. is it time to change? Data from the ARPEC Project. PLoS ONE 2016;11:e0154662.
27. Bruce J, MacKenzie FM, Cookson B, et al. Antibiotic stewardship and consumption: findings from a pan-European hospital study. J Antimicrob Chemother 2009;64:853-60.
28. ECDC. European Centre for Disease Prevention and Control (ECDC)-EARS-net database. Secondary European Centre for Disease Prevention and Control (ECDC)-EARS-net database. 2015. http://www.ecdc.europa.eu/en/healthtopics/antimicrobial-resistance/ database/Pages/database.aspx
29. Lukac PJ, Bonomo RA, Logan LK. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat. Clin Infect Dis 2015;60:1389-97.
30. Drew RJ, Turton JF, Hill RL, et al. Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital. J Hosp Infect 2013;84:300-4.
31. Gravatt LA, Pakyz AL. Challenges in measuring antibiotic consumption. Curr Infect Dis Rep 2013;15:559-63.
32. Ahmed Z, McLeod MC, Barber N, et al. The use and functionality of electronic prescribing systems in English acute NHS trusts: a cross-sectional survey. PLoS ONE 2013;8:e80378.
33. Willemsen I, Groenhuijzen A, Bogaers D, et al. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother 2007;51:864-7.
34. Lestner JM, Versporten A, Doerholt K, et al. Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study. Antimicrob Agents Chemother 2015;59:782-9.